Consistency of Effect with a Low-Dose, Estradiol Vaginal Capsule (TX-004HR): Evaluating Improvement in Vaginal Physiology and Moderate-to-Severe Dyspareunia in Subgroups of Postmenopausal Women

Background: The 12-week, randomized, double-blind, placebo-controlled, multicenter, phase 3 REJOICE trial demonstrated that TX-004HR, an investigational, applicator-free, low-dose vaginal softgel capsule containing solubilized 17β-estradiol, effectively and rapidly treats symptoms of vulvar and vagi...

Descripción completa

Detalles Bibliográficos
Autores principales: Constantine, Ginger D., Bouchard, Celine, Pickar, James H., Archer, David F., Graham, Shelli, Bernick, Brian, Mirkin, Sebastian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc. 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5512333/
https://www.ncbi.nlm.nih.gov/pubmed/28355090
http://dx.doi.org/10.1089/jwh.2016.6187

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5512333/
https://www.ncbi.nlm.nih.gov/pubmed/28355090
http://dx.doi.org/10.1089/jwh.2016.6187

Ejemplares similares